Kissei Pharmaceutical (KSPHF) News Today $30.28 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock KSPHF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Kissei Pharmaceutical Secures Licensing for TED Treatments in JapanJuly 30, 2025 | tipranks.comKissei Pharmaceutical Completes Treasury Stock Disposal for Board and OfficersJuly 24, 2025 | tipranks.comKissei Pharmaceutical Expands TAVALISSE Launch to South KoreaJune 30, 2025 | tipranks.comKissei Pharmaceutical Introduces Restricted Stock Compensation SystemJune 24, 2025 | tipranks.comKissei Pharmaceutical Completes Treasury Share Acquisition and Plans CancellationMay 7, 2025 | tipranks.comKissei Pharmaceutical FY Net Y11.96B Vs Net Y11.16BMay 7, 2025 | marketwatch.comKissei Pharmaceutical Revamps Executive Compensation SystemMay 7, 2025 | tipranks.comJefferies Sticks to Their Hold Rating for Kissei Pharmaceutical Co (KSPHF)March 17, 2025 | markets.businessinsider.comKissei Pharmaceutical Advances with Linzagolix for Uterine FibroidsFebruary 26, 2025 | tipranks.comKissei’s Tavalisse Gains Approval in South Korea for Chronic ITPJanuary 20, 2025 | tipranks.comKissei and Ferring Terminate Co-promotion Agreement for Desmopressin ProductsJanuary 13, 2025 | tipranks.comKissei Expands Market for Tavalisse in Taiwan Through New PartnershipJanuary 7, 2025 | tipranks.comKissei Pharmaceutical Reports Strong Sales Growth Amid Higher R&D CostsNovember 7, 2024 | markets.businessinsider.comKissei Pharmaceutical Plans Share Buyback and CancellationNovember 5, 2024 | msn.comKSPHF Kissei Pharmaceutical Co., Ltd.October 26, 2024 | seekingalpha.comKissei Pharmaceutical earnings: here's what Wall Street expectsJuly 29, 2024 | markets.businessinsider.comKissei Pharmaceutical Co LtdJune 20, 2023 | morningstar.comMKissei Pharmaceutical Co Ltd (4547)May 18, 2023 | investing.comKissei Pharmaceutical Co. Ltd.April 19, 2023 | wsj.comKissei Pharmaceutical Co., Ltd. (KSPHF)January 16, 2023 | finance.yahoo.comKissei Pharmaceutical is about to announce earnings — here's what Wall Street expectsFebruary 2, 2022 | markets.businessinsider.comKissei Pharmaceutical Co. Ltd (KSPHF)January 11, 2022 | nasdaq.comWhat Wall Street expects from Kissei Pharmaceutical's earningsNovember 10, 2021 | markets.businessinsider.com Get Kissei Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for KSPHF and its competitors with MarketBeat's FREE daily newsletter. Email Address KSPHF Media Mentions By Week KSPHF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KSPHF News Sentiment▼0.000.75▲Average Medical News Sentiment KSPHF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KSPHF Articles This Week▼00▲KSPHF Articles Average Week Get Kissei Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for KSPHF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News Today FFNTF News Today ABSCF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today AVCNF News Today BIOYF News Today CBGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KSPHF) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kissei Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kissei Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access